NeonMind Biosciences

CSE:NEON
OTC: NMDBF
Request Investor Info

NeonMind is an integrated psychedelic drug development and wellness company focused on the potential therapeutic uses of psilocybin for treating obesity and weight management conditions which are underpinned by behaviour and mental health.

Projects
Stories
Presentation
Contact
Management
Financials
NeonMind Biosciences Stock Price Today
NeonMind Biosciences Fundamental Data by TradingView

Company Feed

NeonMind psychedelics
May 5, 2021

NeonMind Biosciences: Treat Obesity & Health Issues with Psychedelics

NeonMind is an integrated psychedelic drug development and wellness company focused on the potential therapeutic uses of psilocybin for treating obesi …

This is some text inside of a div block.
NeonMind psychedelic therapy for weight loss
April 30, 2021

NeonMind Bioscience: Innovative Solutions for Health and Obesity

NeonMind is engaged in research and development of products to optimize human health and performance. NeonMind has two divisions, a pharmaceutical div …

This is some text inside of a div block.
Subscribe and receive the investor Info